MODULAR MEDICAL, INC.: 10-Q/A filed 2022-11-17

Name: MODULAR MEDICAL, INC.: 10-Q/A filed 2022-11-17
Creator: MODULAR MEDICAL, INC.

What MODULAR MEDICAL, INC. reported in its quarterly report amendment filed 2022-11-17 (fiscal Q2 2023): 24 published measures, 70 facts as tagged in accession 0001019056-22-000654.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2022-11-17
Fiscal period: fiscal Q2 2023
Accession: 0001019056-22-000654 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MODULAR MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-09-30	11,437,637	USD
At 2022-03-31	9,846,446	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-09-30	695,113	USD
At 2022-03-31	1,009,656	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-09-30	10,742,524	USD
At 2022-06-30	13,450,491	USD
At 2022-03-31	8,836,790	USD
At 2021-09-30	-5,100,814	USD
At 2021-06-30	-1,581,488	USD
At 2021-03-31	-1,275,149	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2022-09-30	10,840,597	USD
At 2022-03-31	9,076,372	USD
At 2021-09-30	798,161	USD
At 2021-03-31	1,468,465	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-3,450,407	USD	92
2022-04-01 to 2022-09-30	-6,949,198	USD	183
2022-04-01 to 2022-06-30	-3,498,791	USD	91
2021-07-01 to 2021-09-30	-4,381,757	USD	92
2021-04-01 to 2021-09-30	-9,216,848	USD	183
2021-04-01 to 2021-06-30	-4,835,091	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-04-01 to 2022-09-30	-5,526,848	USD	183
2021-04-01 to 2021-09-30	-4,784,725	USD	183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2022-04-01 to 2022-09-30	81,274	USD	183
2021-04-01 to 2021-09-30	22,779	USD	183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-04-01 to 2022-09-30	7,372,347	USD	183
2021-04-01 to 2021-09-30	4,137,200	USD	183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2022-04-01 to 2022-09-30	-81,274	USD	183
2021-04-01 to 2021-09-30	-22,779	USD	183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-09-30	-41,528,969	USD
At 2022-03-31	-34,579,771	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	1,600	USD	92
2022-04-01 to 2022-09-30	1,600	USD	183
2021-07-01 to 2021-09-30	1,600	USD	92
2021-04-01 to 2021-09-30	1,600	USD	183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2022-09-30	257,053	USD
At 2022-03-31	235,959	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2022-04-01 to 2022-09-30	1,481,009	USD	183
2021-04-01 to 2021-09-30	1,518,351	USD	183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-3,449,111	USD	92
2022-04-01 to 2022-09-30	-6,948,201	USD	183
2021-07-01 to 2021-09-30	-3,694,412	USD	92
2021-04-01 to 2021-09-30	-7,068,000	USD	183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-09-30	11,005,163	USD
At 2022-03-31	9,389,794	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	685,793	USD	92
2021-04-01 to 2021-09-30	1,194,670	USD	183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-09-30	695,113	USD
At 2022-03-31	969,699	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	3,449,111	USD	92
2022-04-01 to 2022-09-30	6,948,201	USD	183
2021-07-01 to 2021-09-30	3,694,412	USD	92
2021-04-01 to 2021-09-30	7,068,000	USD	183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	2,385,539	USD	92
2022-04-01 to 2022-09-30	4,607,523	USD	183
2021-07-01 to 2021-09-30	2,105,380	USD	92
2021-04-01 to 2021-09-30	3,893,511	USD	183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-09-30	10,925,723	shares
At 2022-03-31	10,461,898	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-09-30	52,260,567	USD
At 2022-03-31	43,406,099	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2022-09-30	75,421	USD
At 2022-03-31	120,693	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-3,448,807	USD	92
2022-04-01 to 2022-09-30	-6,947,598	USD	183
2021-07-01 to 2021-09-30	-4,380,157	USD	92
2021-04-01 to 2021-09-30	-9,215,248	USD	183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	1,063,572	USD	92
2022-04-01 to 2022-09-30	2,340,678	USD	183
2021-07-01 to 2021-09-30	1,589,032	USD	92
2021-04-01 to 2021-09-30	3,174,489	USD	183

Inspect the source

Entity: MODULAR MEDICAL, INC. / CIK 0001074871
Captured: 2026-09-20T05:20:05.018Z
SEC response SHA-256: 35d9c7a349fec6383baca56e8aa4820d6d19d2f4955371898b75285f3bf308e4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001074871.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))